Investor Relations

Allergan Acquires Tobira Therapeutics

On November 1, 2016 Allergan plc (NYSE: AGN), a leading global pharmaceutical company, announced that it had successfully completed the acquisition of Tobira Therapeutics, Inc.

For more information, please visit www.allergan.com

Financial Information